Suppliers / Glochem Industries

Glochem Industries

India 244 employees Updated 9 July 2026

Glochem Industries is an API manufacturer based in India. It holds 18 active US drug master files across a filed portfolio of 10 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 28 June 2024 as VAI. Customs aggregates show $9.1M of exports covering 308 molecules to 44 destinations in 2025.

18
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
3 of 3 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 28 June 2024 VAI US FDA
  • 17 April 2015 NAI US FDA
  • 7 September 2012 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Sangareddy District, India 3005818804

What they file, and where

Molecule Regulators Docs
Amlodipine US FDA 4
Cetirizine SFDA (Saudi Arabia), US FDA 3
Carbidopa US FDA 2
Hydroxyzine US FDA 2
Levocetirizine US FDA 2
Raloxifene US FDA 2
Telmisartan US FDA 2
Eprosartan US FDA 1
Levocetirizine Dihydrochloride SFDA (Saudi Arabia) 1
Tolcapone US FDA 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA None 1

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $1.3M 17
2025 Not reported $9.1M 44
2024 Not reported $6.4M 46
2023 Not reported $6.6M 36

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Glochem Industries

Does Glochem Industries hold a US DMF or a CEP?
Glochem Industries holds 18 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Glochem Industries FDA-registered?
One site operated by Glochem Industries carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Glochem Industries's last inspection go?
The most recent inspection on record closed on 28 June 2024 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 3 inspections are on file.
Where does Glochem Industries manufacture?
1 registered site is on record, in India (Sangareddy District). Every site is listed on this page with the register it came from.
What does Glochem Industries make?
10 molecules are on record against Glochem Industries, including Amlodipine, Cetirizine, Carbidopa and Hydroxyzine. Each links through to that molecule's full manufacturer list.
Which regulators recognise Glochem Industries's GMP?
Current GMP certificates are on record from US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Glochem Industries comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 28 June 2024.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts